Safety of Everolimus Plus Exemestane In Patients With Hormone-Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Progressing on Prior Non-Steroidal Aromatase Inhibitors: Primary Results of a Phase 3b, Open-Label, Single-Arm, Expanded-Access Multicenter Trial (BALLET)

Authors :: Jerusalem, G
Mariani, G
Ciruelos, EM
Martin, M
Tjan-Heijnen, VCG
Neven, Patrick
Gavila, JG
Michelotti, A
Montemurro, F
Generali, D
Simoncini, E
Lang, I
Mardiak, J
Naume, B
Camozzi, M
Lorizzo, K
Bianchetti, S
Conte, P
Publication Year :: 2016
Publisher :: Kluwer Academic Publishers, 2016.
Abstract: This European phase 3b, expanded-access multicenter trial evaluated the safety of EVE plus EXE in a patient population similar to BOLERO-2. ispartof: Annals of Oncology vol:27 issue:9 pages:1719-1725 ispartof: location:England status: published

Tools